A compelling investment opportunity
To date, the initial research, manufacturing and safety trials for ΔGŪ have cost around US $60 million. Funding to date has come from the US Department of Defense, the University of Oxford, the US National Institute of Health, the Technology Strategy Board and Angel investors.
TΔSŪ now requires investment that will allow the company to accelerate commercialisation of ΔGŪ.
To achieve these goals, TΔSŪ now seeks corporate and institutional investors with expertise or interest in the area of sports and performance drinks. This will help the company achieve its stated target of commercialising first products based on ΔGŪ within the next year.
For further information on this unique opportunity, please contact email@example.com